生物医学领域中国作者发表文献的撤稿分析

随着生物医学领域文献发表量的快速增加,撤稿量也随之增加。本文通过检索PubMed收录的关于中国作者发表文章的撤稿文件,对其中的信息进行提取和统计学分析。结果显示:1)生物医学领域中国作者撤稿在2005年后进入快速增长,平均撤稿时间为16.55月,撤稿主要集中在影响因子为0～3的期刊(58.9％)。2)撤稿原因分别为重复发表或抄袭(40%),科学错误(15％),作者署名或版权问题(8%),伪造数据或怀疑伪造数据(5%)。3)因科学错误、重复发表或抄袭、伪造数据或怀疑伪造数据而撤稿的期刊平均影响因子之间差异无统计学意义(P>0.05)。4)非SCI给出不详撤稿信息的比例明显高于SCI期刊(P<0.05)。撤稿行为是对缺陷科学结论纠错的有效措施,从PubMed收录的对中国作者的撤稿声明分析中可以发现某些中国作者科学失范行为的模式,以及科技期刊编辑部对待撤稿的态度,并可借鉴经验制定出有针对性的措施,促进国内期刊出版环境的净化。

Retraction analysis of Chinese authors in biomedicine

Retraction increases with the rapid increase of publication of biomedical research outcomes. This article analyzed the retraction information of papers published by Chinese authors in PubMed, and the results showed that 1)The peak of retraction from Chinese authors appeared after 2005, which is consistent with the increase of research outcomes of Biomedicine. The average time of retraction is 16.55 months, and 58.9% retraction was performed by journals with impact factor of 1-3. 2) Duplicate publication or plagiarism is the most common reason for retraction, accounting for 40%, followed by scientific error (15%) and Copyright problem (8%). 3) There isn''t difference among impact factors of journals performing retraction because of error, duplicate publication/plagiarism and fraud/suspected fraud(P>0.05). 4) The rate of retraction note without detailed information is significant higher in journals, which isn''t included by Science Citation Index, than those in SCI database. Retraction is a correction for scientific misconduct, evidences of anomie behavior model of Chinese authors and attitude of editorial department of scientific journals were proved from the retraction analysis to help to establish coping strategy and purify scientific publication.